3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
22
Neoplasms
16
Leukemia, Myeloid, Acute
10
Ovarian Neoplasms
7
Neoplasm Metastasis
7
Lung Neoplasms
7
Lymphoma
6
Hematologic Neoplasms
6
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Multiple Myeloma
5
Glioblastoma
5
Stomach Neoplasms
4
Leukemia
4
Fatigue
4
Carcinoma, Non-Small-Cell Lung
4
Vulvar Neoplasms
3
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma
3
Pancreatic Neoplasms
3
Pain
3
Myelodysplastic Syndromes
3
Motor Activity
3
Melanoma
3
Depression
3
Anxiety Disorders
3
Vaginal Neoplasms
2
Rectal Neoplasms
2
Interventions
sacubitril and valsartan sodium hydrate drug combination
3
Nutrition Assessment
3
Exercise
3
Carvedilol
3
dapagliflozin
2
Standard of Care
2
Rituximab
2
Ivabradine
2
Control Groups
2
Atorvastatin
2
pertuzumab
1
pegfilgrastim
1
obinutuzumab
1
nicotinamide-beta-riboside
1
empagliflozin
1
candesartan
1
acalabrutinib
1
Vincristine
1
Valsartan
1
Trastuzumab
1
Surveys and Questionnaires
1
Spironolactone
1
Sodium Chloride
1
Simendan
1
Secondary Prevention
1
Resistance Training
1
Pyruvic Acid
1
Prednisolone
1
Practice Guidelines as Topic
1
Population Groups
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Heart Failure
×
Palliative Care
×
Clear all
NCT04598646
2025-12-03
HIMALAYAS-P
University Health Network, Toronto
Phase NA
Completed
30 enrolled